Professor Georgina LongClinician

Biography

Professor Georgina Long AO is Medical Director of Melanoma Institute Australia (MIA) and Chair of Melanoma Medical Oncology and Translational Research at MIA, Royal North Shore Hospital, and the University of Sydney. She is a medical oncologist and clinical trialist specialising in melanoma, leading an extensive clinical trials team focused on immuno-oncology and targeted therapies, including Phase I–III trials in patients with active brain metastases. She completed a PhD in Chemistry and a Fulbright Postdoctoral Fellowship at the Scripps Research Institute before returning to Australia to qualify in medicine, becoming a Fellow of the Australasian College of Physicians in medical oncology in 2008. She was jointly named 2024 Australian of the Year with colleague Professor Richard Scolyer AO, recognised for their immunotherapy approach that has made advanced melanoma a curable disease for many patients. She is a past president of the Society for Melanoma Research (2018–2020) and is known for publicly advocating against tanning culture and for expanded access to cancer clinical trials.

References

1. 1.Professor Georgina Long AO | Melanoma Institute Australia — Current role title, organisation, academic affiliations, research focus, clinical trials leadership, and career background
2. 2.Professor Georgina Long AO and Professor Richard Scolyer AO | Australian of the Year — 2024 Australian of the Year joint award; advocacy role as media commentators on melanoma prevention
3. 3.2018 NSW Premier's Awards for Outstanding Cancer Research — Outstanding Cancer Researcher of the Year 2018 award
4. 4.Prof Georgina Long AO | Medical Oncologist | Mater Hospital, North Sydney — Past presidency of Society for Melanoma Research; ASCO/ESMO committee roles; 200+ conference presentations
5. 5.Contact Us | Melanoma Institute Australia

Expertise

Cited on

• Cancer

Stated areas of expertise

• Melanoma immunotherapy
• Targeted cancer therapies
• Oncology clinical trials
• Translational cancer research
• Cancer biomarkers
• Sun-safe public advocacy

Notable achievements

• Jointly named 2024 Australian of the Year (with Professor Richard Scolyer AO) for pioneering melanoma immunotherapy research that has made advanced melanoma curable for many patients. Source ↗
• Named NSW Premier's Outstanding Cancer Researcher of the Year 2018 by Cancer Institute NSW. Source ↗
• First woman and first Australian to be named president of the US-based Society for Melanoma Research. Source ↗
• Has presented her work at international conferences and meetings on more than 200 occasions. Source ↗

What they’ve said

• “Long wanted to try everything to save her friend and Scolyer was willing to "give it a crack", knowing that their findings could make a significant difference to the lives of future brain cancer patients.”

  co-director of the Melanoma Institute Australia · Cancer · 27 Aug 2026 · Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituary ↗

• “Today's results represent a landmark moment for adjuvant melanoma treatment”

  Medical Director of Melanoma Institute Australia · Cancer · 27 Aug 2026 · Moderna’s cancer shot: exciting for investors, inconclusive for patients ↗

Source references

1. Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituarytheguardian.com · 27 Aug 2026
2. Moderna’s cancer shot: exciting for investors, inconclusive for patientsft.com · 27 Aug 2026

Contact & links

• Staff pagehttps://melanoma.org.au/news/team/professor-georgina-long-ao/
• Press office emailmedia@melanoma.org.aupublished here ↗

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.